Besides BRCA1/2, the implication in CRC occurrence of FANCJ/BRIP1 mutations, a moderate-risk factor for ovarian cancer, has attracted considerable attention [27,28,29,83,86,94,95]. This evidence concerns the gene BRIP1 and ovarian cancer.